PharmaTimes | Industry News | World News | Bayer reportedly settles Trasylol suits for $60m: "German drugmaker Bayer AG has reportedly pulled $60 million out of its wallet to settle around 150 lawsuits relating to its blood loss agent Trasylol, which was yanked from the market in 2007 on safety concerns.
People close to the case (but not authorised to speak about it) claim that Bayer has agreed pay each patient around $400,000 to settle this particular batch of suits relating to Trasylol (aprotinin), Bloomberg reported yesterday.
No comments:
Post a Comment